Drug Firms, Plans Can Claim Small Wins In New Part D Formulary Guidelines

While drug plans and manufacturers can each claim small victories in the updated version of U.S. Pharmacopeia's model guidelines for Medicare Part D formularies, overall the number of drugs that will need to be placed on formularies has not changed significantly, despite a number of changes from both the original 2006 guidelines and the draft revisions for the 2007 version